Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Surface Oncology Inc
(NQ:
SURF
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Surface Oncology Inc
< Previous
1
2
3
Next >
Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences
August 31, 2023
Urges Stockholders to Vote Promptly to Ensure Their Shares are Represented at the September 7th Special Meeting
From
Surface Oncology, Inc.
Via
GlobeNewswire
SURFACE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF
August 07, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023
August 02, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Health Care Company Coherus BioSciences Announces Merger With Surface Oncology
June 16, 2023
Via
Benzinga
Recap: Surface Oncology Q1 Earnings
May 04, 2023
Via
Benzinga
Downgrade Aside, Cathie Wood Buys $1.2M Worth Of SoFi Shares
July 27, 2023
Via
Benzinga
Cathie Wood's Ark Pours $3.3M More Into This Chipmaker Amid AI Frenzy: Here Are Other Major Monday Trades
July 11, 2023
Via
Benzinga
Cathie Wood's Ark Outshines S&P 500, Nasdaq In H1: Here Are The Major Trades It Made
June 28, 2023
Via
Benzinga
Cathie Wood Sells $7M Tesla Stock Friday Amid Pullback, Bets Big On This Crypto-Linked Stock
June 24, 2023
Via
Benzinga
SURFACE ONCOLOGY INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surface Oncology, Inc. - SURF
June 21, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Synergy Of Coherus And Surface Oncology: Analyst Forecasts $50M Savings And 2024 Profitability
June 20, 2023
Truist Securities analyst Robyn Karnauskas reiterated a Buy rating on the shares of Coherus BioSciences, Inc.
Via
Benzinga
Nasdaq Down 80 Points; US Consumer Sentiment Surges To 4-Month High In June
June 16, 2023
U.S. stocks traded lower toward the end of trading, with Nasdaq Compsoite dropping around 80 points on Friday. The Dow traded down 0.24% to 34,324.18 while the NASDAQ fell 0.59% to 13,701.06. The S&P...
Via
Benzinga
Crude Oil Rises; Adobe Posts Upbeat Results
June 16, 2023
U.S. stocks traded slightly higher midway through trading, with Dow Jones gaining around 20 points on Friday. The Dow traded up 0.06% to 34,428.13 while the NASDAQ rose 0.05% to 13,789.23. The S&P 500,...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023
June 20, 2023
Via
Benzinga
Coherus BioSciences, MicroVision, Millicom And Other Big Stocks Moving Lower On Friday
June 16, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording losses in today’s session. Coherus BioSciences, Inc. (NASDAQ: CHRS) tumbled 16.8%...
Via
Benzinga
Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 16, 2023
Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781.
Via
Benzinga
SURF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surface Oncology, Inc. Is Fair to Shareholders
June 16, 2023
From
Halper Sadeh LLC
Via
Business Wire
US Stocks Mixed; Dow Gains 50 Points
June 16, 2023
U.S. stocks traded mixed this morning, with Dow Jones gaining around 50 points on Friday. Following the market opening Friday, the Dow traded up 0.16% to 34,464.01 while the NASDAQ fell 0.14% to...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 16, 2023
Via
Benzinga
Coherus BioSciences Acquires Small Immuno-Oncology Player Surface Oncology For $40M
June 16, 2023
Coherus BioSciences Inc (NASDAQ: CHRS) has agreed to acquire Surface Oncology Inc (NASDAQ: SURF), a clinical-stage immuno-oncology (I-O) company developing next-generation immunotherapies that
Via
Benzinga
Coherus to Acquire Surface Oncology
June 16, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023
May 04, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023
April 18, 2023
– New in vivo data show SRF114 promotes a pro-inflammatory tumor microenvironment resulting in robust antitumor activity in mouse models –
From
Surface Oncology, Inc.
Via
GlobeNewswire
Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research (AACR) Annual Meeting 2023
March 16, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2022
March 09, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Surface Oncology to Participate in the Cowen 43rd Annual Health Care Conference
February 28, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
February 09, 2023
Via
Benzinga
Surface Oncology to Participate in the 2023 Guggenheim Oncology Days Conference
February 02, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
The 3 Best Biotech Stocks Under $1 to Buy for January
January 26, 2023
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich.
Via
InvestorPlace
Vaccinex Announces First Patient Dosed with Anti-CCR8 Antibody Licensed to Surface Oncology
January 09, 2023
Surface Oncology initiates clinical trial with antibody discovered using Vaccinex’s ActivMAb® Antibody Discovery Platform
From
Vaccinex, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.